High Tech Pharm Co., Ltd. (KOSDAQ: 106190)
South Korea
· Delayed Price · Currency is KRW 13,740
-230 (-1.65%)
Sep 11, 2024, 2:32 PM KST
High Tech Pharm Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Other Revenue | -0 | -0 | - | - | 0 | -0 | Upgrade
|
| Revenue | 83,502 | 76,772 | 102,947 | 73,287 | 74,462 | 63,068 | Upgrade
|
| Revenue Growth (YoY) | -11.26% | -25.43% | 40.47% | -1.58% | 18.07% | -5.00% | Upgrade
|
| Cost of Revenue | 63,724 | 63,938 | 95,177 | 70,216 | 73,155 | 65,189 | Upgrade
|
| Gross Profit | 19,778 | 12,834 | 7,770 | 3,071 | 1,308 | -2,122 | Upgrade
|
| Selling, General & Admin | 3,120 | 2,601 | 2,705 | 3,310 | 4,551 | 2,330 | Upgrade
|
| Other Operating Expenses | 67.56 | 61.83 | 47.33 | 115.54 | 30.1 | 25.97 | Upgrade
|
| Operating Expenses | 3,265 | 2,745 | 2,843 | 3,483 | 4,631 | 2,403 | Upgrade
|
| Operating Income | 16,513 | 10,089 | 4,927 | -412.02 | -3,324 | -4,525 | Upgrade
|
| Interest Expense | -867.24 | -896.47 | -463.69 | -252.07 | -327.02 | -290.18 | Upgrade
|
| Interest & Investment Income | 4.52 | 4.69 | 4.31 | 84.73 | 96.39 | 261.49 | Upgrade
|
| Currency Exchange Gain (Loss) | 654.05 | 278.34 | -829.89 | -290.52 | 493.51 | -263.76 | Upgrade
|
| Other Non Operating Income (Expenses) | 275.24 | 282.41 | 267.28 | 1.82 | 466.46 | 1,085 | Upgrade
|
| EBT Excluding Unusual Items | 16,580 | 9,758 | 3,905 | -868.07 | -2,595 | -3,732 | Upgrade
|
| Gain (Loss) on Sale of Investments | 145.5 | 115.56 | 54.65 | - | - | -172.92 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -9.51 | 68.11 | 0.14 | -5 | - | Upgrade
|
| Pretax Income | 16,725 | 9,864 | 4,028 | -867.94 | -2,600 | -3,905 | Upgrade
|
| Income Tax Expense | 3,203 | 1,787 | -1,845 | 357.46 | 552.52 | 312.98 | Upgrade
|
| Net Income | 13,522 | 8,076 | 5,873 | -1,225 | -3,152 | -4,218 | Upgrade
|
| Net Income to Common | 13,522 | 8,076 | 5,873 | -1,225 | -3,152 | -4,218 | Upgrade
|
| Net Income Growth | 70.51% | 37.52% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 7 | 7 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 7 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Change (YoY) | -33.55% | -33.37% | 0.14% | -0.00% | -0.08% | 0.01% | Upgrade
|
| EPS (Basic) | 1910.97 | 1139.33 | 552.00 | -115.33 | -296.67 | -396.67 | Upgrade
|
| EPS (Diluted) | 1910.97 | 1139.33 | 552.00 | -115.33 | -296.67 | -396.67 | Upgrade
|
| EPS Growth | 156.58% | 106.40% | - | - | - | - | Upgrade
|
| Free Cash Flow | 3,075 | -2,183 | -4,359 | 6,068 | -8,628 | 326.68 | Upgrade
|
| Free Cash Flow Per Share | 434.58 | -307.89 | -409.70 | 571.13 | -812.06 | 30.72 | Upgrade
|
| Gross Margin | 23.69% | 16.72% | 7.55% | 4.19% | 1.76% | -3.36% | Upgrade
|
| Operating Margin | 19.78% | 13.14% | 4.79% | -0.56% | -4.46% | -7.17% | Upgrade
|
| Profit Margin | 16.19% | 10.52% | 5.70% | -1.67% | -4.23% | -6.69% | Upgrade
|
| Free Cash Flow Margin | 3.68% | -2.84% | -4.23% | 8.28% | -11.59% | 0.52% | Upgrade
|
| EBITDA | 21,596 | 15,075 | 10,472 | 5,139 | 2,128 | 978.1 | Upgrade
|
| EBITDA Margin | 25.86% | 19.64% | 10.17% | 7.01% | 2.86% | 1.55% | Upgrade
|
| D&A For EBITDA | 5,083 | 4,986 | 5,545 | 5,551 | 5,452 | 5,503 | Upgrade
|
| EBIT | 16,513 | 10,089 | 4,927 | -412.02 | -3,324 | -4,525 | Upgrade
|
| EBIT Margin | 19.78% | 13.14% | 4.79% | -0.56% | -4.46% | -7.17% | Upgrade
|
| Effective Tax Rate | 19.15% | 18.12% | - | - | - | - | Upgrade
|
| Advertising Expenses | - | 97.61 | 84.51 | 13.86 | 26.59 | 44.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.